drug

trientine tetrahydrochloride

Marketedupdated 2mo ago

by Orphalan SA

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 28, 2029

~2.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

May 3, 2039compositionUS 10988436
May 3, 2039method-of-use (U-3370)US 11072577
May 3, 2039compositionUS 12358861
May 3, 2039compositionUS 12358862

FDA exclusivities (1)

Apr 28, 2029ODE-401Orphan Drug (7y)2.8y

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?